High Content Imaging Market Size, Share & Growth Report 2031
High Content Imaging Market Size, Share & Growth Report 2031
Segments - High Content Imaging Market by Type (Instruments, Consumables, Software, and Services), By Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Other Applications), By End User (Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast -2022-2030
Upcoming
| Report ID :HC-5337
| 4.4 Rating
| 71 Reviews
| 239 Pages
| Format :
Report Description
High Content Imaging Market Outlook
The global high content imaging market size was estimated at USD 831.7 Mn in 2021 and is anticipated to reach USD 2,001.0 Mn by 2030, expanding at a CAGR of 10.5% during the forecast period, 2022-2030.
High content imaging is a highly automated three-step method that is used to significantly boost imaging throughput and quantification. These three steps are: Image Acquisition, Image Processing and Image Analysis. It uses fluorescent detection, multiparameter algorithms, automated microscopy, and automated microscopy to observe & measure the interaction of therapeutics in cell populations.
In it each cell in an array is examined at a sub-cellular resolution using multicolored fluorescence-based reagents for both specificity and sensitivity. High levels of computer-driven automation are linked to each stage, enabling users to speed up repetitive tasks and remove human bias from the workflow. Tera-bites of captured data are collected, processed, and analyzed in a matter of minutes with little assistance from humans.
High Content Imaging Market Macro-economic Factors
Rising GDP of Emerging Economies
An emerging market economy refers to a country that is in the process of development. Countries such as Brazil, Russia, India, China (BRIC), and other countries in Latin America & Southeast Asia are key developing economies.
The economic growth of emerging countries is typically growing by 6% to 7% annually, whereas countries with an already well-established economy report growth rates below 3%. Therefore, the GDP growth rates for emerging market economies are outperforming those of developed countries. Thus, the rising GDP of major & emerging economies plays a crucial role in the expansion of the market.
Governmental Spending
Governments across the globe are investing in the medical technology industry to increase real per capita healthcare spending. The medical technology industry is an essential component of the healthcare industry. Healthcare expenditure plays an important role in providing opportunities for maintaining health. It strengthens human capital and improves productivity, thereby contributing to economic performance. The medical technology industry registered an average global investment rate (R&D spending as a proportion of sales) of 8% in 2018.
High Content Imaging Market Dynamics
Major Drivers
Development of novel therapeutics against the SARS-CoV-2 virus
High-content imaging has been used as an efficient tool in identifying new lead compounds for antiviral drug development. Several high-throughput assays were developed and utilized during the early COVID-19 outbreak to scan collections of approved and investigational drugs in order to find possible anti-SARS-CoV-2 compounds.
A panel of assays was developed and used to screen collections of approved and investigational drugs for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity in a quantitative high-throughput screening (qHTS) format in response to the COVID-19 pandemic. Prulifloxacin, tegobuvir, bictegravir, and nelfinavir have been identified by high-throughput screening (HTS) for drugs against 3CLpro.
Rising need for cost containment in pharmaceutical research and development
Drug development is a lengthy, complex, and costly process with a high degree of uncertainty of success. Pharmaceutical companies are being forced to reevaluate their R&D spending, due to the high cost and protracted nature of drug development. Toxicology studies are conducted by screening huge libraries for possible drug candidates. This approach is costly, and time- and resource-consuming, and it has a poor success rate.
High-content imaging solutions are used for testing the potential toxicity of chemicals and complex substances and are being adopted by pharmaceutical companies to advance in-vitro toxicity testing, which reduces the time and cost. This is expected to fuel the high-content imaging market during the forecast period.
Restraints
High Content Imaging should be ingested sparingly, as their excessive consumption can have negative effects on some people. High Content Imaging have negative health effects such as allergies, gastrointestinal problems, and an increase in insulin levels. High Content Imaging are anti-arrhythmic, which require patients to take a doctor’s approval before consuming High Content Imaging.
Excessive consumption of High Content Imaging can lead to calcification in the bones and other parts of the body. High Content Imaging overheat the body. Pregnant women are advised to avoid the consumption of an excessive amount of High Content Imaging to avoid any harm to the unborn child. Thus, side effects & allergies associated with the consumption of High Content Imaging can restrain the market.
Emerging Opportunities
High-content screening (HCS) is a well-established approach for the multiparametric analysis of cellular events. High-content imaging systems have evolved with many improvements to meet user demands of high flexibility and the growing requirements of assays involving complex cellular disease models.
Molecular Devices, LLC launched its next-generation, high-content imaging system, the ImageXpress Confocal HT.ai High-Content Imaging System, which is designed to help researchers advance phenotypic screening of 3D organoid models. Thus, technological advancements in high content imaging are expected to create opportunities for the market growth over the forecast period.
Scope of High Content Imaging Market Report
The report on the global High Content Imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
High Content Imaging Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2015–2020 |
|
Forecast Period |
2022–2030 |
|
Segmentation |
Product (Instruments, Consumables, Software, and Services), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Other Applications), End User (Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization) |
|
Regional Scope |
Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered |
PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc. |
High Content Imaging Market Segmental Outlook
Product Segment Analysis
On the basis of product, the market is segmented into Instruments, Consumables, Software, and Services. Instruments are further subdivided into cell imaging & analysis systems and flow cytometers. Consumables are further subdivided into reagent & assay kits, microplates and other consumables.
The consumables segment is expected to hold a substantial share of the market during the forecast period, as it is helpful in providing high-performance imaging of a biological sample. High-content imaging systems use automated microscopy and fluorescent detection to visualize and quantify the interaction of therapeutics in cell populations.
Application Segment Analysis
Based on By Application, the market is fragmented into primary and Secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. The target identification & validation segment is expected to hold a substantial share of the market during the forecast period, as HCI delivers a functional readout in target validation studies. Target validation shows that a molecular target is directly involved in a disease process and modulation of the target to have a therapeutic effect.
End User Segment Analysis
In terms of the End User, the market is fragmented into Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization. The pharmaceutical & biotechnology company segment is projected to expand at a significant pace, as high-content imaging (HCI) is used in drug development and various clinical & preclinical studies. HCI systems have been witnessing strong demand in the pharmaceutical industry, due to the rising advancements in instrumentation techniques.
Regional Analysis
Based on regions, the market is separated into namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The high growth of high-content imaging in the US is attributed to the rising demand for high-content imaging in the pharmaceutical industry. Government spending on the medical technology industry is anticipated to fuel the high-content imaging market over the forecast period. North America holds a significant instrument segment share. The market in the US is projected to continue registering high growth, owing to the rising use of technologically advanced tools in the drug development process.
The market in Asia Pacific is estimated to grow rapidly, owing to factors such as the increasing number of applications and the growing demand for high-content imaging. Rising research & development activities for medical technologies in many countries such as China and India are expected to contribute to the growth of the market in Asia Pacific.
The high-content imaging market in Latin America is estimated to expand at a considerable CAGR during the forecast period. Emerging economies in the region are expected to register significant growth, due to the growing demand for high-content imaging in compound profiling.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global High Content Imaging Market
- Historical, Current, and Projected Market Size in terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global High Content Imaging Market Performance
Segments
Product
- Instruments
- Cell Imaging & Analysis Systems
- Flow Cytometers
- Consumables
- Reagent & Assay Kits
- Microplates
- Other Consumables
- Software
- Services
Application
- Primary and Secondary Screening
- Target Identification and Validation
- Toxicity Studies
- Compound Profiling
- Other Applications
End User
- Pharmaceutical & Biotechnology Companies
- Academic and Government Institutes
- Contract Research Organization
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Market Players Profiled in the Report
- PerkinElmer Inc
- Agilent Technologies, Inc
- Thermo Fisher Scientific Inc
- Charles River Laboratories
- Danaher (Molecular Devices, LLC)
- Yokogawa Electric Corporation
- Miltenyi Biotec
- Nikon Corporation (Nikon Instruments Inc),
- Zeiss Group (arivis AG)
- Aligned Genetics, Inc
Competitive Landscape
Manufacturers operating in the global high content imaging market include PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.
Market Players are pursuing key strategies such as collaborations, mergers & acquisitions, and geographic expansion where a potential opportunity rises for the global high content imaging market.
Frequently Asked Questions
The base year considered for the Global High Content Imaging Market report is 2021. The complete analysis period is 2015 to 2030, wherein, 2015 to 2020 are the historic years, and the forecast is provided from 2022 to 2030.
In addition to market size (in US$ Million), Company Market Share (in % for the base year 2021), macroeconomic factors, and supply chain analysis, current and future trends, application of high content imaging in HCS assays, application of high content imaging in life science research is given in the report.
Pharmaceutical companies and medical researchers around the globe aim to fast-track drug discovery, development, and clinical trials in response to COVID-19, and are focusing on three key interventional strategies: repurposing of existing drugs, development of therapeutics, and development of vaccines.
Major manufacturers include PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.
Factors such as the rising GDP of Emerging Economies, Governmental Spending and R&D Activities are considered as macroeconomic factors for the report.
According to this Growth Market Reports report, the Global High Content Imaging Market is likely to register a CAGR of 10.5% during the forecast period 2020-2030, with a projected valuation of USD 2,001.0 Million by the end of 2030.
Development of novel therapeutics against the SARS-CoV-2 virus, Rising need for cost containment in pharmaceutical research and development, Enhanced toxicity studies in cell analysis, and Rising use in medicinal products are the factors expected to drive the market growth during the forecast period.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High Content Imaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 High Content Imaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 High Content Imaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the High Content Imaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global High Content Imaging Market Size & Forecast, 2016-2031
4.5.1 High Content Imaging Market Size and Y-o-Y Growth
4.5.2 High Content Imaging Market Absolute $ Opportunity
4.6 Current and Future Trends
4.7 Application of High Content Imaging in HCS Assays
4.8 Application of High Content Imaging in Life Science Research
Chapter 5 Global High Content Imaging Market Analysis and Forecast By Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Product
5.1.2 Basis Point Share (BPS) Analysis By Product
5.1.3 Absolute $ Opportunity Assessment By Product
5.2 High Content Imaging Market Size Forecast By Product
5.2.1 Instruments
5.2.2 Consumables
5.2.3 Software
5.2.4 Services
5.3 Market Attractiveness Analysis By Product
Chapter 6 Global High Content Imaging Market Analysis and Forecast By Application
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Application
6.1.2 Basis Point Share (BPS) Analysis By Application
6.1.3 Absolute $ Opportunity Assessment By Application
6.2 High Content Imaging Market Size Forecast By Application
6.2.1 Primary and Secondary Screening
6.2.2 Target Identification and Validation
6.2.3 Toxicity Studies
6.2.4 Compound Profiling
6.2.5 Other Applications
6.3 Market Attractiveness Analysis By Application
Chapter 7 Global High Content Imaging Market Analysis and Forecast By End User
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By End User
7.1.2 Basis Point Share (BPS) Analysis By End User
7.1.3 Absolute $ Opportunity Assessment By End User
7.2 High Content Imaging Market Size Forecast By End User
7.2.1 Pharmaceutical & Biotechnology Companies
7.2.2 Academic and Government Institutes
7.2.3 Contract Research Organization
7.3 Market Attractiveness Analysis By End User
Chapter 8 Global High Content Imaging Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 High Content Imaging Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America High Content Imaging Analysis and Forecast
10.1 Introduction
10.2 North America High Content Imaging Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America High Content Imaging Market Size Forecast By Product
10.6.1 Instruments
10.6.2 Consumables
10.6.3 Software
10.6.4 Services
10.7 Basis Point Share (BPS) Analysis By Product
10.8 Absolute $ Opportunity Assessment By Product
10.9 Market Attractiveness Analysis By Product
10.10 North America High Content Imaging Market Size Forecast By Application
10.10.1 Primary and Secondary Screening
10.10.2 Target Identification and Validation
10.10.3 Toxicity Studies
10.10.4 Compound Profiling
10.10.5 Other Applications
10.11 Basis Point Share (BPS) Analysis By Application
10.12 Absolute $ Opportunity Assessment By Application
10.13 Market Attractiveness Analysis By Application
10.14 North America High Content Imaging Market Size Forecast By End User
10.14.1 Pharmaceutical & Biotechnology Companies
10.14.2 Academic and Government Institutes
10.14.3 Contract Research Organization
10.15 Basis Point Share (BPS) Analysis By End User
10.16 Absolute $ Opportunity Assessment By End User
10.17 Market Attractiveness Analysis By End User
Chapter 11 Europe High Content Imaging Analysis and Forecast
11.1 Introduction
11.2 Europe High Content Imaging Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe High Content Imaging Market Size Forecast By Product
11.6.1 Instruments
11.6.2 Consumables
11.6.3 Software
11.6.4 Services
11.7 Basis Point Share (BPS) Analysis By Product
11.8 Absolute $ Opportunity Assessment By Product
11.9 Market Attractiveness Analysis By Product
11.10 Europe High Content Imaging Market Size Forecast By Application
11.10.1 Primary and Secondary Screening
11.10.2 Target Identification and Validation
11.10.3 Toxicity Studies
11.10.4 Compound Profiling
11.10.5 Other Applications
11.11 Basis Point Share (BPS) Analysis By Application
11.12 Absolute $ Opportunity Assessment By Application
11.13 Market Attractiveness Analysis By Application
11.14 Europe High Content Imaging Market Size Forecast By End User
11.14.1 Pharmaceutical & Biotechnology Companies
11.14.2 Academic and Government Institutes
11.14.3 Contract Research Organization
11.15 Basis Point Share (BPS) Analysis By End User
11.16 Absolute $ Opportunity Assessment By End User
11.17 Market Attractiveness Analysis By End User
Chapter 12 Asia Pacific High Content Imaging Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific High Content Imaging Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific High Content Imaging Market Size Forecast By Product
12.6.1 Instruments
12.6.2 Consumables
12.6.3 Software
12.6.4 Services
12.7 Basis Point Share (BPS) Analysis By Product
12.8 Absolute $ Opportunity Assessment By Product
12.9 Market Attractiveness Analysis By Product
12.10 Asia Pacific High Content Imaging Market Size Forecast By Application
12.10.1 Primary and Secondary Screening
12.10.2 Target Identification and Validation
12.10.3 Toxicity Studies
12.10.4 Compound Profiling
12.10.5 Other Applications
12.11 Basis Point Share (BPS) Analysis By Application
12.12 Absolute $ Opportunity Assessment By Application
12.13 Market Attractiveness Analysis By Application
12.14 Asia Pacific High Content Imaging Market Size Forecast By End User
12.14.1 Pharmaceutical & Biotechnology Companies
12.14.2 Academic and Government Institutes
12.14.3 Contract Research Organization
12.15 Basis Point Share (BPS) Analysis By End User
12.16 Absolute $ Opportunity Assessment By End User
12.17 Market Attractiveness Analysis By End User
Chapter 13 Latin America High Content Imaging Analysis and Forecast
13.1 Introduction
13.2 Latin America High Content Imaging Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America High Content Imaging Market Size Forecast By Product
13.6.1 Instruments
13.6.2 Consumables
13.6.3 Software
13.6.4 Services
13.7 Basis Point Share (BPS) Analysis By Product
13.8 Absolute $ Opportunity Assessment By Product
13.9 Market Attractiveness Analysis By Product
13.10 Latin America High Content Imaging Market Size Forecast By Application
13.10.1 Primary and Secondary Screening
13.10.2 Target Identification and Validation
13.10.3 Toxicity Studies
13.10.4 Compound Profiling
13.10.5 Other Applications
13.11 Basis Point Share (BPS) Analysis By Application
13.12 Absolute $ Opportunity Assessment By Application
13.13 Market Attractiveness Analysis By Application
13.14 Latin America High Content Imaging Market Size Forecast By End User
13.14.1 Pharmaceutical & Biotechnology Companies
13.14.2 Academic and Government Institutes
13.14.3 Contract Research Organization
13.15 Basis Point Share (BPS) Analysis By End User
13.16 Absolute $ Opportunity Assessment By End User
13.17 Market Attractiveness Analysis By End User
Chapter 14 Middle East & Africa (MEA) High Content Imaging Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) High Content Imaging Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By Product
14.6.1 Instruments
14.6.2 Consumables
14.6.3 Software
14.6.4 Services
14.7 Basis Point Share (BPS) Analysis By Product
14.8 Absolute $ Opportunity Assessment By Product
14.9 Market Attractiveness Analysis By Product
14.10 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By Application
14.10.1 Primary and Secondary Screening
14.10.2 Target Identification and Validation
14.10.3 Toxicity Studies
14.10.4 Compound Profiling
14.10.5 Other Applications
14.11 Basis Point Share (BPS) Analysis By Application
14.12 Absolute $ Opportunity Assessment By Application
14.13 Market Attractiveness Analysis By Application
14.14 Middle East & Africa (MEA) High Content Imaging Market Size Forecast By End User
14.14.1 Pharmaceutical & Biotechnology Companies
14.14.2 Academic and Government Institutes
14.14.3 Contract Research Organization
14.15 Basis Point Share (BPS) Analysis By End User
14.16 Absolute $ Opportunity Assessment By End User
14.17 Market Attractiveness Analysis By End User
Chapter 15 Competition Landscape
15.1 High Content Imaging Market: Competitive Dashboard
15.2 Global High Content Imaging Market: Market Share Analysis, 2022
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 PerkinElmer Inc
15.3.2 Thermo Fisher Scientific Inc
15.3.3 Agilent Technologies, Inc
15.3.4 Charles River Laboratories
15.3.5 Danaher (Molecular Devices, LLC)
15.3.6 Yokogawa Electric Corporation
15.3.7 Miltenyi Biotec
15.3.8 Nikon Corporation (Nikon Instruments Inc
15.3.9 Zeiss Group (arivis AG)
15.3.10 Aligned Genetics, Inc
Methodology
Related Reports
Some other reports from this category!
Our Clients
